Skip to main content
NACFC 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestreamed Session
Livestreamed Session
Ticketed Session
Ticketed Session
Recorded Session
Recorded Session
Back

Alexandra L. Quittner, PhD (she/her/hers)

Joe DiMaggio Cystic Fibrosis Center

Alexandra L. Quittner, PhD, is currently a Senior Scientist at Joe DiMaggio Cystic Fibrosis, Pulmonary and Sleep Center, formerly a professor for over 32 years. She has been continuously funded by NIH and other foundation and agencies, and has published over 230 articles and book chapters. She received the Richard C. Talamo Clinical Research Award from the Cystic Fibrosis Foundation in 2008 in recognition of her development of the first health-related quality of life measures for cystic fibrosis (CFQ-R), which are now used worldwide in clinical trials of new medications. In 2016, she was awarded the CF Foundation Richard Mattingly Award in Mental Health Care for her international epidemiological study of depression and anxiety in patients and caregivers. She is now co-leading a national dissemination and implementation effort to translate mental health screening into clinical care. She is working on several clinical research grants funded by the CF Foundation including development of the GEMS-CF screener and launching the TIDES 2.0 epidemiological study for children under 12 years. ; She is leading a national effort to assess professional quality of life and burnout in CF healthcare providers. She currently chairs the Research Subcommittee of the CFF Mental Health Advisory Committee. She has focused her research on cystic fibrosis and other rare lung diseases and has developed the first disease-specific quality of life measures for: CF, non-CF bronchiectasis, NTM, and primary ciliary dyskinesia. She has long-standing research interests in the measurement and promotion of adherence behaviors and the assessment and treatment of mental health in chronic pulmonary diseases. She is collaborating on several intervention studies addressing mental health challenges in cystic fibrosis.

Presentation(s):